NewsRx

Search our medical news database

Chronic Disease

Amedisys Welcomes Julie L. Lewis as Vice President of Health Policy and Government Relations

Published in Health and Medicine Week, February 28th, 2011

2011 FEB 28 -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home care and hospice companies, recently announced that Julie L. Lewis will serve as Vice President of Health Policy and Government Relations.

In this new role, Ms. Lewis is assisting Amedisys in the continued development of a patient-centered, value-driven agenda for effective chronic disease management and end-of-life care that focuses on the quality and sustainability of the U.S. health care system. Ms. Lewis works with hospitals, physicians, and private payers to develop pilots to test new delivery and payment models for post-acute, palliative, and chronic disease care. She also...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook